Palladium Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.17M | Sell |
28,433
-940
| -3% | -$99.3K | 0.14% | 115 |
|
|
2021
Q4 | $3.06M | Sell |
29,373
-424
| -1% | -$49.1K | 0.13% | 115 |
|
|
2021
Q3 | $3.73M | Buy |
29,797
+9,978
| +50% | +$1.29M | 0.17% | 100 |
|
|
2021
Q2 | $2.46M | Sell |
19,819
-611
| -3% | -$76.7K | 0.12% | 118 |
|
|
2021
Q1 | $2.41M | Sell |
20,430
-876
| -4% | -$103K | 0.12% | 117 |
|
|
2020
Q4 | $2.5M | Sell |
21,306
-8,939
| -30% | -$984K | 0.14% | 109 |
|
|
2020
Q3 | $3.14M | Sell |
30,245
-3,973
| -12% | -$399K | 0.2% | 93 |
|
|
2020
Q2 | $3.14M | Sell |
34,218
-3,206
| -9% | -$307K | 0.22% | 93 |
|
|
2020
Q1 | $3.38M | Sell |
37,424
-1,897
| -5% | -$202K | 0.28% | 83 |
|
|
2019
Q4 | $4.46M | Sell |
39,321
-74,027
| -65% | -$8.12M | 0.29% | 87 |
|
|
2019
Q3 | $11.2M | Sell |
113,348
-10,603
| -9% | -$1.11M | 0.78% | 40 |
|
|
2019
Q2 | $12.1M | Buy |
123,951
+7,095
| +6% | +$648K | 0.84% | 34 |
|
|
2019
Q1 | $10.6M | Buy |
116,856
+2,553
| +2% | +$228K | 0.77% | 39 |
|
|
2018
Q4 | $10.4M | Buy |
114,303
+900
| +0.8% | +$84.1K | 0.83% | 38 |
|
|
2018
Q3 | $11.2M | Buy |
113,403
+2,299
| +2% | +$213K | 0.76% | 40 |
|
|
2018
Q2 | $9.51M | Buy |
111,104
+1,898
| +2% | +$159K | 0.69% | 46 |
|
|
2018
Q1 | $8.76M | Buy |
109,206
+3,345
| +3% | +$276K | 0.65% | 48 |
|
|
2017
Q4 | $8.55M | Buy |
105,861
+9,168
| +9% | +$734K | 0.62% | 49 |
|
|
2017
Q3 | $7.52M | Buy |
+96,693
| New | +$8.03M | 0.57% | 51 |
|
|
2017
Q1 | – | Sell |
-2,841
| Closed | -$202K | – | 256 |
|
|
2016
Q4 | $202K | Sell |
2,841
-4,649
| -62% | -$365K | 0.02% | 246 |
|
|
2016
Q3 | $647K | Buy |
7,490
+795
| +12% | +$69.3K | 0.06% | 167 |
|
|
2016
Q2 | $581K | Sell |
6,695
-189
| -3% | -$15.3K | 0.05% | 169 |
|
|
2016
Q1 | $516K | Sell |
6,884
-871
| -11% | -$65.6K | 0.05% | 177 |
|
|
2015
Q4 | $597K | Sell |
7,755
-5,045
| -39% | -$380K | 0.06% | 171 |
|
|
2015
Q3 | $857K | Sell |
12,800
-1,907
| -13% | -$140K | 0.08% | 149 |
|
|
2015
Q2 | $1.09M | Sell |
14,707
-243
| -2% | -$18.6K | 0.1% | 150 |
|
|
2015
Q1 | $1.17M | Sell |
14,950
-242
| -2% | -$18.3K | 0.1% | 154 |
|
|
2014
Q4 | $1.1M | Sell |
15,192
-26
| -0.2% | -$1.81K | 0.1% | 159 |
|
|
2014
Q3 | $943K | Sell |
15,218
-582
| -4% | -$37K | 0.08% | 166 |
|
|
2014
Q2 | $1.01M | Buy |
15,800
+400
| +3% | +$24.3K | 0.09% | 162 |
|
|
2014
Q1 | $948K | Hold |
15,400
| – | – | 0.09% | 163 |
|
|
2013
Q4 | $884K | Hold |
15,400
| – | – | 0.08% | 167 |
|
|
2013
Q3 | $820K | Buy |
15,400
+7,150
| +87% | +$385K | 0.08% | 167 |
|
|
2013
Q2 | $425K | Buy |
+8,250
| New | +$408K | 0.04% | 197 |
|
Other funds holding MDT
WA
Palladium Partners's MDT Position: Q1 2022 in Review
Palladium Partners reduced its Medtronic (MDT) stake by 3.2% in Q1 2022, selling an estimated $99.3K and leaving 28,433 shares worth $3.17M. The position accounts for 0.14% of the portfolio, ranked #115.
Palladium Partners first reported a position in MDT in Q2 2013 and has held it in 34 quarters since. The position peaked at $12.1M in Q2 2019. 2,102 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Palladium Partners held 28,433 shares of Medtronic worth $3.17M as of Q1 2022.
- Palladium Partners sold 940 Medtronic shares in Q1 2022, an estimated $99.3K.
- Medtronic made up 0.14% of Palladium Partners's portfolio in Q1 2022, its #115 holding.
- Palladium Partners first reported a position in Medtronic in Q2 2013 and has held it in 34 quarters since.
- Palladium Partners's Medtronic position peaked at $12.1M in Q2 2019.
- 2,102 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.